Versant Capital Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.8K Hold
405
– – ﹤0.01% 1706
2026
Q2
$41.7K Hold
405
– – ﹤0.01% 1496
2026
Q1
$15.5K Buy
+405
New +$12.8K ﹤0.01% 1946
2025
Q4
– Sell
-362
Closed -$7.77K – 2650
2025
Q3
$7.77K Buy
362
+340
+1,545% +$7.62K ﹤0.01% 2036
2025
Q2
$564 Sell
22
-20
-48% -$585 ﹤0.01% 2541
2025
Q1
$1.54K Buy
42
+40
+2,000% +$1.38K ﹤0.01% 2309
2024
Q4
$61 Buy
+2
New +$66 ﹤0.01% 2362
2023
Q3
– Sell
-16
Closed -$507 – 1945
2023
Q2
$507 Buy
+16
New +$517 ﹤0.01% 1831
2019
Q3
– Sell
-5
Closed – – 1364
2019
Q2
$0 Buy
+5
New +$211 ﹤0.01% 1398

Other funds holding ATEX

Versant Capital Management's ATEX Position: Q3 2026 in Review

Versant Capital Management held its Anterix (ATEX) position steady in Q3 2026 at 405 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

Versant Capital Management first reported a position in ATEX in Q2 2019 and has held it in 9 quarters since. The position peaked at $41.7K in Q2 2026. 66 funds tracked by Wall St. Rank hold ATEX as of Q3 2026.

  • Versant Capital Management held 405 shares of Anterix worth $31.8K as of Q3 2026.
  • Versant Capital Management left its Anterix share count unchanged in Q3 2026.
  • Anterix made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1706 holding.
  • Versant Capital Management first reported a position in Anterix in Q2 2019 and has held it in 9 quarters since.
  • Versant Capital Management's Anterix position peaked at $41.7K in Q2 2026.
  • 66 funds tracked by Wall St. Rank held Anterix as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.